Abstract

BI-RADS, introduced by the ACR in 1993, has standardized the language and reporting structure used for breast cancer screening examinations, categorization of risk on the basis of imaging findings, and recommendations for follow-up imaging and management of potential breast tumors [1]. Since that time, the widespread adoption of BI-RADS has likely contributed to reduced variation in the quality of breast imaging care. However, recent work has shown that patients in traditionally disadvantaged demographic groups have reduced rates of follow-up for abnormal screening findings, which is a likely mechanism underlying at least some of the persistent disparities in breast cancer outcomes [2].

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.